Main page content

Displaying results 1 - 10 of 16
Publication ID: PEP21-05-00-001
Published:

This document provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws. This guide applies to parity laws in employer-sponsored health plans and group and individual insurance.

Publication ID: PEP21-07-01-004
Published:

This report provides an update on a series of topics focusing on substance use and mental health (collectively referred to as behavioral health) in the United States. SAMHSA selected specific topics and indicators in this report to represent a cross-section of the key behavioral health indicators that are assessed in SAMHSA data collections, including NSDUH. This report is intended to provide a concise, reader-friendly summary of key behavioral health measures for lay and professional audiences.

Publication ID: PEP19-ANTIPSYCHOTIC-BP
Published:

This Guidance document gives a “bird’s eye view” of strategies to support best practice prescribing of antipsychotics for youth and summarizes the available evidence and principles to support these strategies.

Publication ID: SMA19-5097
Published:

This guide provides information and practices that behavioral health providers can implement in their daily practice with patients or clients who are involved in the criminal justice system.

Publication ID: SMA16-4999
Published:

The report highlights the need for HIV treatment providers to address behavioral health concerns with HIV. The report urges providers to start with screening for mental health and substance use disorders, and offers strategies for providers to implement screening practices.

Publication ID: SMA16-4985
Published:

This manual offers guidance on how to engage youth during government-sponsored events and meetings. It includes resources to support youth services, youth development, youth leadership, civic engagement, and youth organizing.

Publication ID: SMA16-4938
Published:

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Publication ID: SMA15-4908
Published:

This report presents spending information for treatment of mental illness, substance use disorders, or both for people only enrolled in Medicaid, and those enrolled in both Medicaid and Medicare. The report also covers fee-for-service spending and managed care spending.

Publication ID: SMA14-4854
Published:

This report presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. It covers treatment effectiveness and cost effectiveness. The report also offers examples of innovative approaches in Vermont, Massachusetts, and Maryland.

Publication ID: SMA14-4804
Published:

This fact sheet answers common questions for behavioral health treatment and service providers about the International Classification of Diseases, 10th Edition (ICD-10) code sets.

Displaying 1 - 10 out of 16